Rational design of self‐assembled mitochondria‐ targeting lytic peptide conjugates with enhanced tumor selectivity

Author(s):  
sijin Liu ◽  
Biao Wang ◽  
Yina Sheng ◽  
suwei Dong ◽  
Guoquan Liu
2012 ◽  
Vol 51 (18) ◽  
pp. 4388-4392 ◽  
Author(s):  
Xiaoli Zhang ◽  
Xinlei Chu ◽  
Ling Wang ◽  
Huaimin Wang ◽  
Gaolin Liang ◽  
...  

Small ◽  
2019 ◽  
Vol 15 (2) ◽  
pp. 1970010
Author(s):  
Xin-Jie Zhu ◽  
Ri-Fei Li ◽  
Liang Xu ◽  
Hui Yin ◽  
Long Chen ◽  
...  

2021 ◽  
Author(s):  
Serena Gentile ◽  
Erica Del Grosso ◽  
Leonard J. Prins ◽  
Francesco Ricci

Taking advantage of the addressability and programmability of DNA/DNA non-covalent interactions we report here the rational design of orthogonal DNA-based addressable tiles that self-assemble into polymer-like structures that can be reconfigured and reorganized by external inputs. The different tiles share the same 5-nucleotide sticky ends responsible for self-assembly but are rationally designed to contain a specific regulator-binding domain that can be orthogonally targeted by different DNA regulator strands (activators and inhibitors). We show that by sequentially adding specific activators and inhibitors it is possible to re-organize in a dynamic and reversible way the formed polymer-like structures to display well-defined distributions: homopolymers made of a single tile, random polymers in which different tiles are distributed randomly and block structures in which the tiles are organized in segments.


2013 ◽  
Author(s):  
Sita Aggarwal ◽  
Ted Gauthier ◽  
Hector Alila ◽  
Carola Leuschner ◽  
Namrata Karki ◽  
...  

2016 ◽  
Vol 18 (33) ◽  
pp. 22757-22771 ◽  
Author(s):  
Jin Wen ◽  
Wei Li ◽  
Shuang Chen ◽  
Jing Ma

Simulations using QM and MM methods guide the rational design of functionalized SAMs on surfaces.


2020 ◽  
Vol 6 (45) ◽  
pp. eabc1725
Author(s):  
Yinxian Yang ◽  
Bingjun Sun ◽  
Shiyi Zuo ◽  
Ximu Li ◽  
Shuang Zhou ◽  
...  

Rational design of nanoparticulate drug delivery systems (nano-DDS) for efficient cancer therapy is still a challenge, restricted by poor drug loading, poor stability, and poor tumor selectivity. Here, we report that simple insertion of a trisulfide bond can turn doxorubicin homodimeric prodrugs into self-assembled nanoparticles with three benefits: high drug loading (67.24%, w/w), high self-assembly stability, and high tumor selectivity. Compared with disulfide and thioether bonds, the trisulfide bond effectively promotes the self-assembly ability of doxorubicin homodimeric prodrugs, thereby improving the colloidal stability and in vivo fate of prodrug nanoassemblies. The trisulfide bond also shows higher glutathione sensitivity compared to the conventional disulfide bond, and this sensitivity enables efficient tumor-specific drug release. Therefore, trisulfide bond–bridged prodrug nanoassemblies exhibit high selective cytotoxicity on tumor cells compared with normal cells, notably reducing the systemic toxicity of doxorubicin. Our findings provide new insights into the design of advanced redox-sensitive nano-DDS for cancer therapy.


Sign in / Sign up

Export Citation Format

Share Document